At least three law firms are advising in Chinese medical technology firm Baird Medical Investment Holdings Limited’s go-public merger with a special purpose acquisition company in a deal valuing the post-merger company at $370 million.
Dechert LLP is advising Guangzhou, China-headquartered Baird Medical, while Shearman & Sterling is counseling the San Francisco-based SPAC, ExcelFin Acquisition Corp. ExcelFin’s sponsors include private equity firm Grand Fortune Capital, LLC, an affiliate of a Hong Kong investment firm, and Fin Venture Capital, a San Francisco-based private equity firm.
Ropes & Gray is representing ExcelFin’s lead financial and capital markets adviser, Cohen & Company Capital ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.